Webinar
Webcast Optimizing CDK 4/6 inhibition in HR+ HER2- advanced breast cancer Click on the presentation links (right) to view the individual free webcast sessions Click here to watch the full webcast Click on the presentation links below to watch the individual sessions by Javier Cortes, Nadia Harbeck and George W Sledge Jr. The webcast includes […]
Optimizing CDK4/6 inhibition in HR+ HER2- advanced breast cancer
Program launch date: 19th September 2020 Accreditation expiration date: 3rd December 2021 Welcome to this independent medical education program on the optimal use of CDK4/6 inhibitors to treat HR+ HER2- advanced breast cancer. This program is designed for global oncologists and other healthcare professionals involved in the diagnosis, treatment, and follow-up of patients with breast […]
Treating Metastatic Renal Cell Carcinoma
Treating metastatic renal cell carcinoma: Patient case studies Program launch date: 16th November 2020The development of several targeted treatment options has revolutionized the treatment of metastatic RCC. Dr Axel Merseburger invites you to participate in this three-part case study series which looks at how to manage metastatic renal cell carcinoma (RCC). In the first case study, […]
Pathway tool
Webcast
Discussion and guidance on the characterization of EGFR mutation-positive tumor subtypes, appropriate sequencing of treatment and management of EGFR TKI resistance. Program launch date: 19th October 2020Webcast accreditation expiration date: 5th November 2021Treatment Pathway accreditation expiration date: 17th February 2022 https://vimeo.com/644307189 Introduction to the program Program director Faculty Learning objectives Accreditation Educational grant Introduction to […]
Pathway tool
Program launch date: 13th March 2020 Access our new interactive and instructional tool, designed to help you navigate the different treatment lines of non-driver NSCLC. It is targeted at international (medical and radiation) oncologists and any other healthcare professionals involved in the diagnosis, treatment, and follow-up of patients with lung cancer. Select your region: North […]
Oncology
This page is not currently in use
Targeting improved outcomes in EGFR-mutated NSCLC
Webcast Discussion and guidance on the characterization of EGFR mutation-positive tumor subtypes, appropriate sequencing of treatment and management of EGFR TKI resistance. Pathway Follow a patient’s progression using this interactive pathway as we support your clinical treatment decision-making supported by trial data and expert opinion. An expert-driven program addressing the optimal treatment strategy for patients […]
